Physician

Andrew Beaumont, M.D., PH.D.

According to 2025 Medicare claims, Andrew Beaumont, M.D., PH.D. (NPI: 1871688135) practices neurosurgery in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ASPIRUS MEDICAL GROUP, INC. (NPI: 1568765550; TIN: 391670223) and primary practice location at 54401-4120.

Beaumont's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 561 HCPCS/CPT codes, and received $140,064 in Medicare payments. The top billing code was 63047 (Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment). Part D data shows 487 prescription claims across 155 beneficiaries totaling $3,121 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). DME data shows 18 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $166,947 and ending at $140,064. Concurrently, Part D prescription costs have declined steadily, from $6,881 to $3,121. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $85,036 and ending at $74,995.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	173	590	$166,947
2016	200	759	$215,675
2017	287	979	$267,816
2018	277	800	$216,245
2019	265	749	$168,853
2020	251	720	$159,240
2021	251	876	$229,044
2022	227	891	$248,292
2023	237	769	$212,073
2024	199	561	$140,064

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	241	$6,881
2016	85	297	$7,743
2017	115	469	$18,391
2018	123	417	$7,628
2019	179	551	$85,359
2020	125	419	$12,420
2021	162	508	$6,168
2022	156	490	$4,778
2023	151	571	$4,729
2024	155	487	$3,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	25	$84,642
2016	40	40	$132,592
2017	47	47	$159,314
2018	45	45	$154,256
2019	27	27	$94,629
2020	21	21	$74,682
2021	40	40	$141,483
2022	36	36	$132,110
2023	32	32	$129,809
2024	18	18	$74,916

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
63047	Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment	39	39	$535
63048	Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment	45	90	$143
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	34	34	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	56	67	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	40	40	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	621	$672
Gabapentin	Gabapentin	72	1,939	$449
Tizanidine Hcl	Tizanidine Hcl	72	1,239	$358
Oxycodone Hcl	Oxycodone Hcl	64	433	$341
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	725	$240

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0748	Osteogenesis stimulator, electrical, non-invasive, spinal applications	N	18	18	$74,916

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Andrew Beaumont, M.D., PH.D.?

Tedicare shows public-source Medicare data for Andrew Beaumont, M.D., PH.D. (NPI 1871688135), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Beaumont, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Beaumont, M.D., PH.D.?

Andrew Beaumont, M.D., PH.D. is linked to ASPIRUS MEDICAL GROUP, INC. (billing NPI 1568765550) in the available physician profile data.

Does Andrew Beaumont, M.D., PH.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.